Novavax shares rise after company unveils positive vaccine data, plan to cut 25% of workforce

Novavax still reported bleak first-quarter earnings and revenue that missed Wall Street's estimates.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.